Liver Transplant in Hepatocellular Carcinoma: Indication and Prognostic Factors

Gunawan - - (Department of Internal Medicine, Medistra Hospital, Jakarta)
Irsan Hasan (Division of Hepatobiliary, Department of Internal Medicine, Faculty of Medicine University of Indonesia /Dr. Cipto Mangunkusumo General National Hospital, Jakarta)
Juferdy Kurniawan (Division of Hepatobiliary, Department of Internal Medicine, Faculty of Medicine University of Indonesia /Dr. Cipto Mangunkusumo General National Hospital, Jakarta)

The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy
Vol 16, No 2 (2015): VOLUME 16, NUMBER 2, August 2015

Hepatocellular carcinoma (HCC) is the most common type of liver cancer. There are several treatment modalities according to Barcelona treatment algorithm. Liver transplant is one of the curative option treatments, with its indication and prognostic factors. Carefully selected patients for liver transplant in HCC case will result in the same or slightly inferior survival rate compare with liver transplant in non-malignancy case.